Literature DB >> 20385764

Ubiquitin-independent degradation of antiapoptotic MCL-1.

Daniel P Stewart1, Brian Koss, Madhavi Bathina, Rhonda M Perciavalle, Kristen Bisanz, Joseph T Opferman.   

Abstract

Antiapoptotic myeloid cell leukemia 1 (MCL-1) is an essential modulator of survival during the development and maintenance of a variety of cell lineages. Its turnover, believed to be mediated by the ubiquitin-proteasome system, facilitates apoptosis induction in response to cellular stress. To investigate the contribution of ubiquitinylation in regulating murine MCL-1 turnover, we generated an MCL-1 mutant lacking the lysine residues required for ubiquitinylation (MCL-1(KR)). Here, we demonstrate that despite failing to be ubiquitinylated, the MCL-1(KR) protein is eliminated at a rate similar to that of wild-type MCL-1 under basal and stressed conditions. Moreover, the degradation of wild-type MCL-1 is not affected when ubiquitin-activating enzyme E1 activity is blocked. Likewise, both wild-type and MCL-1(KR) proteins are similarly degraded when expressed in primary lymphocytes. Supporting these findings, unmodified, in vitro-translated MCL-1 can be degraded in a cell-free system by the 20S proteasome. Taken together, these data demonstrate that MCL-1 degradation can occur independently of ubiquitinylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385764      PMCID: PMC2876674          DOI: 10.1128/MCB.01266-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins.

Authors:  C Akgul; D A Moulding; M R White; S W Edwards
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

2.  UBE1L2, a novel E1 enzyme specific for ubiquitin.

Authors:  Christiane Pelzer; Ingrid Kassner; Konstantin Matentzoglu; Rajesh K Singh; Hans-Peter Wollscheid; Martin Scheffner; Gunter Schmidtke; Marcus Groettrup
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

3.  Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.

Authors:  A M Domina; J H Smith; R W Craig
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics.

Authors:  Silke Reischl; Katja Vanselow; Pål O Westermark; Nadine Thierfelder; Bert Maier; Hanspeter Herzel; Achim Kramer
Journal:  J Biol Rhythms       Date:  2007-10       Impact factor: 3.182

5.  Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.

Authors:  Jianping Jin; Xue Li; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

6.  E1-L2 activates both ubiquitin and FAT10.

Authors:  Yu-Hsin Chiu; Qinmiao Sun; Zhijian J Chen
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

7.  N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.

Authors:  Alfredo De Biasio; Julie A Vrana; Ping Zhou; Liping Qian; Christine K Bieszczad; Karen E Braley; Aaron M Domina; Steven J Weintraub; John M Neveu; William S Lane; Ruth W Craig
Journal:  J Biol Chem       Date:  2007-06-08       Impact factor: 5.157

8.  Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.

Authors:  Jonathan R Hall; Evelyn Kow; Kathleen R Nevis; Chiajung Karen Lu; K Scott Luce; Qing Zhong; Jeanette Gowen Cook
Journal:  Mol Biol Cell       Date:  2007-06-13       Impact factor: 4.138

9.  Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome.

Authors:  Xueyan Chen; Lance F Barton; Yong Chi; Bruce E Clurman; James M Roberts
Journal:  Mol Cell       Date:  2007-06-22       Impact factor: 17.970

10.  Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment.

Authors:  Stephen W G Tait; Evert de Vries; Chiel Maas; Anna M Keller; Clive S D'Santos; Jannie Borst
Journal:  J Cell Biol       Date:  2007-12-31       Impact factor: 10.539

View more
  68 in total

Review 1.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

2.  Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors.

Authors:  Daniel Kraus; Pratheeba Palasuberniam; Bin Chen
Journal:  Photochem Photobiol       Date:  2019-12-17       Impact factor: 3.421

3.  Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.

Authors:  Dorothy Lo; Mu-Shui Dai; Xiao-Xin Sun; Shelya X Zeng; Hua Lu
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

4.  A Bim-activating mould.

Authors:  G Häcker
Journal:  Cell Death Differ       Date:  2013-10       Impact factor: 15.828

5.  Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site.

Authors:  Matthew R Warr; John R Mills; Mai Nguyen; Stephanie Lemaire-Ewing; Jason Baardsnes; Karen L W Sun; Abba Malina; Jason C Young; Danny V Jeyaraju; Maureen O'Connor-McCourt; Luca Pellegrini; Jerry Pelletier; Gordon C Shore
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

Review 6.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

7.  NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1.

Authors:  A Craxton; M Butterworth; N Harper; L Fairall; J Schwabe; A Ciechanover; G M Cohen
Journal:  Cell Death Differ       Date:  2012-02-24       Impact factor: 15.828

8.  Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons.

Authors:  M M Magiera; S Mora; B Mojsa; I Robbins; I Lassot; S Desagher
Journal:  Cell Death Differ       Date:  2012-09-14       Impact factor: 15.828

9.  Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.

Authors:  Shanna K Nifoussi; Nora R Ratcliffe; Deborah L Ornstein; Gary Kasof; Stefan Strack; Ruth W Craig
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

10.  Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells.

Authors:  Shadia Zaman; Rui Wang; Varsha Gandhi
Journal:  Exp Hematol       Date:  2015-08-06       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.